Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver.

Cyclosporine A (CsA) is the most widely used immunosuppressive drug for preventing graft rejection and autoimmune disease. However, the therapeutic treatment induces several side effects such as nephrotoxicity, cardiotoxicity, hypertension and hepatotoxicity. Among possible mechanisms of CsA-induced hepatic damage, oxidative stress has been suggested. Melatonin (Mel) has been successfully used as a potent antioxidant against many pathophysiological states. This experimental study was performed to test, during CsA treatment, the alterations of some heat shock proteins (HSP) and the Mel antioxidant properties against CsA-induced injury. Rats were divided into four groups, which were treated respectively with olive oil, Mel alone, CsA and CsA plus Mel for 30 days. At the end of the treatments, the animals were killed and hepatic tissue was treated for morphological (haematoxylin-eosin), biochemical (reduced glutathione, GSH and malondialdehyde, MDA) and immunohistochemical (HSP60, HSP72, GRP75 and MT) analyses. The results indicate that CsA-induced hepatotoxicity was characterised by morphological alterations in tissue architecture, changes in GSH and MDA levels and increase in stress protein expression. In conclusion, our data suggest that the imbalance between production of free oxygen radicals and antioxidant defence systems, due to CsA administration, is a mechanism responsible for oxidative stress. Moreover, we show that Mel plays a protective action against CsA-induced oxidative stress, as supported by biochemical and immunohistochemical results.

[1]  A. Fahr,et al.  In vivo pharmacological effects of ciclosporin and some analogues. , 1996, Advances in pharmacology.

[2]  R. Reiter,et al.  Melatonin and mitochondrial function. , 2004, Life sciences.

[3]  A. Ito,et al.  How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies , 1997, FEBS letters.

[4]  R. Wiesner,et al.  Cyclosporine-induced hypertension after transplantation. , 1994, Mayo Clinic proceedings.

[5]  G. Andrews,et al.  Regulation of metallothionein gene expression by oxidative stress and metal ions. , 2000, Biochemical pharmacology.

[6]  O. Feron,et al.  Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium , 2003, FEBS letters.

[7]  H. Parlakpınar,et al.  Efficacy of melatonin as protectant against oxidative stress and structural changes in liver tissue in pinealectomized rats. , 2004, Acta histochemica.

[8]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[9]  S. Pertsov,et al.  Lipid Peroxidation in the Brain and Liver of Rats during Acute Stress and Melatonin Treatment , 2004, Bulletin of Experimental Biology and Medicine.

[10]  F. Marcheselli,et al.  Melatonin: a peroxyl radical scavenger more effective than vitamin E. , 1994, Life sciences.

[11]  J. Borel,et al.  Biological effects of cyclosporin A: A new antilymphocytic agent , 1976, Agents and actions.

[12]  S. Flechner,et al.  HEPATOBILIARY AND PANCREATIC COMPLICATIONS OF CYCLOSPORINE THERAPY IN 466 RENAL TRANSPLANT RECIPIENTS , 1987, Transplantation.

[13]  K. Kumar,et al.  Melatonin: an antioxidant protects against cyclosporine-induced nephrotoxicity. , 1999, Transplantation.

[14]  İ. Durak,et al.  Cyclosporine reduces hepatic antioxidant capacity: protective roles of antioxidants. , 2004, International immunopharmacology.

[15]  L. Rodella,et al.  Change in Renal Heme Oxygenase Expression in Cyclosporine A-induced Injury , 2005 .

[16]  K. Okawa,et al.  A subset of newly synthesized polypeptides in mitochondria from human endothelial cells exposed to hydroperoxide stress. , 2002, Free radical biology & medicine.

[17]  R. Schwartz,et al.  Immunosuppressive therapy. 1. , 1972, The New England journal of medicine.

[18]  A. I. Galán,et al.  S-Adenosylmethionine protects against cyclosporin A-induced alterations in rat liver plasma membrane fluidity and functions. , 1999, The Journal of pharmacology and experimental therapeutics.

[19]  Y. Liu,et al.  Increase in metallothionein produced by chemicals that induce oxidative stress. , 1991, Toxicology and applied pharmacology.

[20]  W. Bennett,et al.  Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations. , 1997, Seminars in nephrology.

[21]  L. Miller Cardiovascular Toxicities of Immunosuppressive Agents , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  R. Reiter,et al.  The Oxidant/Antioxidant Network: Role of Melatonin , 1999, Neurosignals.

[23]  A. Margeli,et al.  Metallothionein and Heat Shock Protein Expression during Acute Liver Injury and Regeneration in Rats , 2000, Clinical chemistry and laboratory medicine.

[24]  R. Reiter,et al.  Acutely administered melatonin reduces oxidative damage in lung and brain induced by hyperbaric oxygen. , 1997, Journal of applied physiology.

[25]  S. Theocharis,et al.  Metallothionein: A Multifunctional Protein from Toxicity to Cancer , 2003, The International journal of biological markers.

[26]  Amy S. Lee,et al.  The glucose-regulated proteins: stress induction and clinical applications. , 2001, Trends in biochemical sciences.

[27]  Jörg Martin Molecular Chaperones and Mitochondrial Protein Folding , 1997, Journal of bioenergetics and biomembranes.

[28]  Josep M. Guerrero,et al.  Reactive Oxygen Intermediates, Molecular Damage, and Aging: Relation to Melatonin , 1998, Annals of the New York Academy of Sciences.

[29]  A. I. Galán,et al.  Inhibition of biliary glutathione secretion by cyclosporine A in the rat: possible mechanisms and role in the cholestasis induced by the drug. , 1998, Journal of hepatology.

[30]  Y. Berland,et al.  The restoration of ATP synthesis may explain the protective effect of calcium antagonists against cyclosporine A nephrotoxicity. , 1992, Life sciences.

[31]  R. Rezzani,et al.  Distribution of heat shock proteins in kidneys of rats after immunosuppressive treatment with cyclosporine A. , 2001, Acta histochemica.

[32]  N. Aksoy,et al.  Effects of melatonin on oxidative–antioxidative status of tissues in streptozotocin‐induced diabetic rats , 2003, Cell biochemistry and function.

[33]  W. Trommer,et al.  Cyclosporine A-induced oxidative stress in rat hepatocytes. , 1997, The Journal of pharmacology and experimental therapeutics.

[34]  A. Crevât,et al.  Action of cyclosporine on mitochondrial calcium fluxes , 1987, Journal of bioenergetics and biomembranes.

[35]  S. Lindquist The heat-shock response. , 1986, Annual review of biochemistry.

[36]  H. Teufelsbauer,et al.  Cyclosporin-A induced heart failure after orthotopic heart transplantation. , 1987, The thoracic and cardiovascular surgeon.

[37]  R. Reiter,et al.  Melatonin—A Highly Potent Endogenous Radical Scavenger and Electron Donor: New Aspects of the Oxidation Chemistry of this Indole Accessed in vitro a , 1994, Annals of the New York Academy of Sciences.

[38]  H. Hagar The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. , 2004, Toxicology Letters.

[39]  S. P. Tomasovic,et al.  Effects of calcium buffering on the synthesis of the 26-kDa heat-shock protein family. , 1991, Radiation research.

[40]  D. Dunn,et al.  CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS , 1978, The Lancet.

[41]  T. Ng,et al.  Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase, and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues. , 2000, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[42]  L. Rodella,et al.  Small Heat Shock Proteins Expression in Rat Kidneys Treated with Cyclosporine A Alone and Combined with Melatonin , 2002, The Histochemical Journal.

[43]  W. Bennett,et al.  Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  H. van Loveren,et al.  Cyclosporin and the rat thymus. An immunohistochemical study. , 1990, Thymus.

[45]  A. Álvarez,et al.  HSP70 induction by cyclosporine A in cultured rat hepatocytes: effect of vitamin E succinate. , 2000, Journal of hepatology.

[46]  P. Bernardi,et al.  Interactions of Cyclophilin with the Mitochondrial Inner Membrane and Regulation of the Permeability Transition Pore, a Cyclosporin A-sensitive Channel (*) , 1996, The Journal of Biological Chemistry.

[47]  G. Crabtree,et al.  The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. , 1990, The EMBO journal.

[48]  R. Rezzani,et al.  Cyclosporine A and adverse effects on organs: histochemical studies. , 2004, Progress in histochemistry and cytochemistry.

[49]  R. Reiter,et al.  Actions of Melatonin in the Reduction of Oxidative Stress , 2000, Journal of Biomedical Science.

[50]  N. Enomoto,et al.  Cyclosporin A causes a hypermetabolic state and hypoxia in the liver: prevention by dietary glycine. , 2001, The Journal of pharmacology and experimental therapeutics.

[51]  W. Savage,et al.  GYNAECOLOGISTS' ATTITUDES TO ABORTION , 1989, The Lancet.

[52]  Cyclosporine-associated hypertension. , 1988, The American journal of medicine.